Locations
South San Francisco, CA, USA · San Francisco, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2021
Sono Thera is a biotechnology company focused on developing an ultrasound-mediated nonviral gene therapy platform aimed at delivering genetic medicines to treat a variety of diseases. Their innovative approach utilizes ultrasound microbubbles for targeted, non-invasive delivery to organs, addressing significant barriers in gene therapy such as safety, efficacy, and cost. With a mission to improve the lives of millions, Sono Thera is positioned to revolutionize the treatment landscape for conditions with limited or no existing therapies, leveraging a technology with an established safety track record and the potential for diverse nucleic acid payloads.
Something looks off?On-site & Remote